1. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Issue 11 (November 2021) Authors: Glasbey, James; Ademuyiwa, Adesoji; Adisa, Adewale; AlAmeer, Ehab; Arnaud, Alexis P; Ayasra, Faris; Azevedo, José; Minaya-Bravo, Ana; Costas-Chavarri, Ainhoa; Edwards, John; Elhadi, Muhammed; Fiore, Marco; Fotopoulou, Christina; Gallo, Gaetano; Ghosh, Dhruva; Griffiths, Ewen A; Harrison, Ewen; H... Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P431 Teduglutide use and nutritional outcomes in short bowel syndrome with intestinal failure: a real-world claims database analysis. (27th May 2021) Authors: Micic, D; Jiang, J; Chen, L; Fan, T; Mu, F; Satija, A; Downes, N; Shrestha, S; Wu, E; Swallow, E; Wojtowicz, A; Raphael, B P Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P597 Cycling Anti-TNF Therapy in Inflammatory Bowel Disease: Effectiveness and Durability of Switching from adalimumab to infliximab. (27th May 2021) Authors: Steinberg, J; Andersen, M; Krugliak Cleveland, N; Traboulsi, C; Rodriguez, T; Cohen, R; Dalal, S; Micic, D; Pekow, J; Atsushi, S; Rubin, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P455 Tofacitinib Therapy is Effective for Arthralgias Associated with Active Inflammatory Bowel Disease. (27th May 2021) Authors: Silfen, A; Cohen, N; Traboulsi, C; Rodriguez, T; Steinberg, J; Singer, J; Patel, S; Cohen, R; Dalal, S; Micic, D; Pekow, J; Sakuraba, A; Rubin, D Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Meta‐Analysis of the Risk of Immune‐Related Adverse Events With Anticytotoxic T‐Lymphocyte‐Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Issue 2 (10th October 2017) Authors: Komaki, Y; Komaki, F; Yamada, A; Micic, D; Ido, A; Sakuraba, A Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 2(2018) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗